Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Detalles Bibliográficos
Autores principales: Restelli, Umberto, Fabbiani, Massimiliano, Di Giambenedetto, Simona, Nappi, Carmela, Croce, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627749/
https://www.ncbi.nlm.nih.gov/pubmed/29026324
http://dx.doi.org/10.2147/CEOR.S143377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627749/
https://www.ncbi.nlm.nih.gov/pubmed/29026324
http://dx.doi.org/10.2147/CEOR.S143377

Ejemplares similares